These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 8472828)

  • 21. Oxitropium bromide, a new anticholinergic bronchodilator.
    Skorodin MS; Gross NJ; Moritz T; King FW; Armstrong W; Wells D; Galavan E; Slutsky L
    Ann Allergy; 1986 Mar; 56(3):229-32. PubMed ID: 3513670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of inhaled ipratropium bromide, fenoterol and their combination in COPD patients.
    Charoenpan P; Kiatboonsri S; Uswanopakhun P; Vongvivat K; Sulaimanee P
    J Med Assoc Thai; 1990 Feb; 73(2):91-5. PubMed ID: 2141057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities].
    Beeh KM; Beier J; Buhl R; Stark-Lorenzen P; Gerken F; Metzdorf N;
    Pneumologie; 2006 Jun; 60(6):341-6. PubMed ID: 16761228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bronchodilatory effects of NVA237, a once daily long-acting muscarinic antagonist, in COPD patients.
    Fogarty C; Hattersley H; Di Scala L; Drollmann A
    Respir Med; 2011 Mar; 105(3):337-42. PubMed ID: 21144724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastric antisecretory activity of telenzepine, a new M1-selective muscarinic antagonist: comparison with pirenzepine.
    Coruzzi G; Adami M; Bertaccini G
    Arch Int Pharmacodyn Ther; 1989; 302():232-41. PubMed ID: 2636819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of pirenzepine-sensitive (M1) muscarinic receptors in vagally mediated bronchoconstriction in humans.
    Lammers JW; Minette P; McCusker M; Barnes PJ
    Am Rev Respir Dis; 1989 Feb; 139(2):446-9. PubMed ID: 2521552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [3 mg telenzepine nocte in the treatment of benign stomach ulcer disease: a double-blind comparative study with 300 mg ranitidine nocte].
    Simon B; Reinicke HG; Dammann HG; Müller P
    Z Gastroenterol; 1990 Feb; 28(2):90-3. PubMed ID: 2181788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of telenzepine on gastrointestinal transit: comparison with placebo and domperidone.
    Armbrecht U; Reul W; Stockbrügger RW
    Z Gastroenterol; 1990 Feb; 28(2):85-9. PubMed ID: 2181787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term effect of the beta2-receptor agonist procaterol on daily life performance and exercise capacity in patients with stable chronic obstructive pulmonary disease. Clinical study with special reference to health-related quality of life and activities of daily living.
    Shioya T; Satake M; Sato K; Sano MA; Sugawara K; Takahashi H; Honma M
    Arzneimittelforschung; 2008; 58(1):24-8. PubMed ID: 18368947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of inhaled beta-adrenergic and anticholinergic drugs on respiratory function and arterial blood gases in patients with pulmonary emphysema].
    Igarashi T; Nishimura M; Akiyama Y; Yamamoto M; Kobayashi S; Miyamoto K; Kawakami Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Jan; 31(1):32-6. PubMed ID: 8096880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxygen desaturation and breathlessness during corridor walking in chronic obstructive pulmonary disease: effect of oxitropium bromide.
    Spence DP; Hay JG; Carter J; Pearson MG; Calverley PM
    Thorax; 1993 Nov; 48(11):1145-50. PubMed ID: 8296259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duration of protection by oxitropium bromide against cholinergic challenge.
    Wilson NM; Green S; Coe C; Barnes PJ
    Eur J Respir Dis; 1987 Nov; 71(5):455-8. PubMed ID: 3327703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of domiciliary nebulizers in managing patients with severe COPD.
    Eiser N; Angus K; McHale S
    Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of the long-acting muscarinic antagonist GSK233705 delivered once daily in patients with COPD.
    Bateman E; Feldman G; Kilbride S; Brooks J; Mehta R; Harris S; Maden C; Crater G
    Clin Respir J; 2012 Oct; 6(4):248-57. PubMed ID: 22329914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Long-term effect of inhaled budesonide in patients with mild to moderate chronic obstructive lung disease. The Osterbro Study].
    Vestbo J; Sørensen T; Lange P; Brix A; Torre P; Viskum K
    Ugeskr Laeger; 2000 Jan; 162(4):493-7. PubMed ID: 10697447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of theophylline in chronic obstructive lung disease.
    Umut S; Gemicioğlu B; Yildirim N; Barlas A; Ozüner Z
    Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):149-52. PubMed ID: 1592541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Present status and future perspectives of muscarinic receptor antagonists.
    Londong W
    Scand J Gastroenterol Suppl; 1986; 125():55-60. PubMed ID: 2881347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exocrine pancreatic secretion in man following one week of M1-muscarinic receptor blockade.
    Malfertheiner P; Nelson DK; Kemmer TP; Glasbrenner B; Schneider A; Ditschuneit H
    Aliment Pharmacol Ther; 1993 Aug; 7(4):423-8. PubMed ID: 8218757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of cold air hyperpnea in patients with chronic obstructive lung disease.
    Arnup ME; Mendella LA; Anthonisen NR
    Am Rev Respir Dis; 1983 Aug; 128(2):236-9. PubMed ID: 6881683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a M1-selective muscarinic receptor antagonist (pirenzepine) on basal bronchomotor tone in young women.
    Fujimura M; Kamio Y; Matsuda T
    Respiration; 1992; 59(2):102-6. PubMed ID: 1620977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.